Felycin®-CA1 (sirolimus delayed-release tablets) 12/Carton

1.2 mg Tablet

PRN PHARMACAL INC
Manufacturer Item #:30091793
Patterson Item #:51-004-5810
Package Quantity: 12/Pkg Active Ingredient: sirolimus Presentation: Tablet Strength: 1.2 mg
See My Price
Quantity
Choose a comparable product or call 1-800-225-7911 for assistance
Overview
Product Specifications

Felycin®-CA1 (Sirolimus Delayed-Release Tablets) is the first FDA conditionally approved medication specifically developed to manage feline hypertrophic cardiomyopathy (HCM). Formulated for oral use in cats, Felycin™-CA1 contains sirolimus, which helps regulate pathways involved in abnormal heart muscle thickening. This prescription medication offers a new approach to feline cardiac care, improving treatment consistency and compliance.

  • First FDA conditionally approved treatment for feline HCM
  • Delayed-release tablets formulated for cats
  • Contains sirolimus to target heart muscle abnormalities
  • Oral administration supports at-home use
  • Designed to improve quality of life in cats with hypertrophic cardiomyopathy

Package Quantity: 12/Pkg Active Ingredient: sirolimus Presentation: Tablet Strength: 1.2 mg NDC Number: 49427-0917-93 Box Color: Blue Color Of Medicine: Blue Container Type: Blister Pack Delivery Type: Oral Pill Count: 12 Reconstitution Required: N NDC Number: 49427-0917-93